Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers

Contemporary Definitions and Classification of the Cardiomyopathies

Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C. N., Corrado, D., Arnett, D. K., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,424 · see citing works

Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases

Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995 · see citing works

American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy

Maron, B. J., McKenna, W. J., Danielson, G. K., KAPPENBERGER, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,572 · see citing works

Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy

Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,466 · see citing works

Hypertrophic Cardiomyopathy

Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., Benaiche, A., Isnard, R., Dubourg, O., Burban, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066323.15244.54 · Cited by 1,273 · see citing works

Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy

Spirito, P., Bellone, P., Harris, K. M., Bernabò, P., Bruzzi, P., & Maron, B. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422403 · Cited by 1,142 · see citing works

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients

Elliot, P. M., Poloniecki, J. D., Dickie, S., Sharma, S., Monserrat, L., Varnava, A. M., Mahon, N., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 976 · see citing works

Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

Olivotto, I., Cecchi, F., Casey, S. A., Dolara, A., Traverse, J. H., & Maron, B. J. (2001) · Circulation · doi:10.1161/hc4601.097997 · Cited by 863 · see citing works

Epidemiology of Hypertrophic Cardiomyopathy–Related Death

Maron, B. J., Olivotto, I., Spirito, P., Casey, S. A., Bellone, P., Gohman, T. E., Graham, K. J., Burton, D. A., & Cecchi, F. (2000) · Circulation · doi:10.1161/01.cir.102.8.858 · Cited by 799 · see citing works

Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., et al. (2007) · JAMA · doi:10.1001/jama.298.4.405 · Cited by 798 · see citing works

Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy

Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., & Camici, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025050 · Cited by 779 · see citing works

Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy

Niimura, H., Bachinski, L. L., Sangwatanaroj, S., Watkins, H. C., Chudley, A. E., McKenna, W. J., Kristinsson, A., Roberts, R., Sole, M. J., Maron, B. J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381802 · Cited by 757 · see citing works

Characteristics and Prognostic Implications of Myosin Missense Mutations in Familial Hypertrophic Cardiomyopathy

Watkins, H. C., Rosenzweig, A., Hwang, D., Levi, T., McKenna, W. J., Seidman, C. E., & Seidman, J. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261703 · Cited by 742 · see citing works

Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy

Monserrat, L., Elliott, P. M., Gimeno, J. R., Sharma, S., Penas-Lado, M., & McKenna, W. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00827-1 · Cited by 541 · see citing works

Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy

Elliot, P. M., Gimeno, J. R., Mahon, N., Poloniecki, J. D., & McKenna, W. J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04005-8 · Cited by 517 · see citing works

Gender-Related Differences in the Clinical Presentation and Outcome of Hypertrophic Cardiomyopathy

Olivotto, I., Maron, M. S., Adabağ, S., Casey, S. A., Vargiu, D., Link, M. S., Udelson, J. E., Cecchi, F., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.043 · Cited by 431 · see citing works

Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy

Elliot, P. M., Gimeno, J. R., Tome, M., Shah, J., Ward, D., Thaman, R., Mogensen, J., & McKenna, W. J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl041 · Cited by 428 · see citing works

Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy

Driest, S. L. V., Vasile, V. C., Ommen, S. R., Will, M. L., Tajik, A. J., Gersh, B. J., & Ackerman, M. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.045 · Cited by 423 · see citing works

Hypertrophic cardiomyopathy in tuscany: Clinical course and outcome in an unselected regional population

Cecchi, F., Olivotto, I., Montereggi, A., Santoro, G., Dolara, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00353-3 · Cited by 296 · see citing works

Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy

Elliot, P. M., Gimeno, J. R., Thaman, R., Shah, J., Ward, D., Dickie, S., Tome, M., & McKenna, W. J. (2005) · Heart · doi:10.1136/hrt.2005.068577 · Cited by 296 · see citing works

Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

Anan, R., Greve, G., Thierfelder, L., Watkins, H. C., McKenna, W. J., Solomon, S. D., Vecchio, C., Shono, H., Nakao, S., & Tanaka, H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116957 · Cited by 285 · see citing works

Clinical Features and Prognostic Implications of Familial Hypertrophic Cardiomyopathy Related to the Cardiac Myosin-Binding Protein C Gene

Charron, P., Dubourg, O., Desnos, M., Bennaceur, M., Carrier, L., Camproux, A., Isnard, R., Hagège, A. A., Jm, L., Bonne, G., et al. (1998) · Circulation · doi:10.1161/01.cir.97.22.2230 · Cited by 279 · see citing works

Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy

Adabag, A. S., Casey, S. A., Kuskowski, M. A., Zenovich, A. G., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.043 · Cited by 273 · see citing works

Natural History of Hypertrophic Cardiomyopathy

Cannan, C. R., Reeder, G. S., Bailey, K. R., Melton, L. J., & Gersh, B. J. (1995) · Circulation · doi:10.1161/01.cir.92.9.2488 · Cited by 265 · see citing works

The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms

Autore, C., Bernabò, P., Barillà, C. S., Bruzzi, P., & Spirito, P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.067 · Cited by 259 · see citing works

Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.

Fananapazir, L., Chang, A. C., Epstein, S. E., & McAreavey, D. (1992) · Circulation · doi:10.1161/01.cir.86.3.730 · Cited by 259 · see citing works

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy

Elliot, P. M., Sharma, S., Varnava, A. M., Poloniecki, J. D., Rowland, E., & McKenna, W. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00056-x · Cited by 257 · see citing works

Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy

Olivotto, I., Maron, B. J., Montereggi, A., Mazzuoli, F., Dolara, A., & Cecchi, F. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00094-7 · Cited by 254 · see citing works

Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.

Epstein, N. D., Cohn, G., Cyran, F., & Fananapazir, L. (1992) · Circulation · doi:10.1161/01.cir.86.2.345 · Cited by 230 · see citing works

Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.

Fananapazir, L., & Epstein, N. D. (1994) · Circulation · doi:10.1161/01.cir.89.1.22 · Cited by 226 · see citing works

Dilated-Hypokinetic Evolution of Hypertrophic Cardiomyopathy

Biagini, E., Coccolo, F., Ferlito, M., Perugini, E., Rocchi, G., Reggiani, M. L. B., Lofiego, C., Boriani, G., Prandstraller, D., Picchio, F. M., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.062 · Cited by 224 · see citing works

Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration

Kofflard, M. J. M., ten Cate, F. J., van der Lee, C., & van Domburg, R. T. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)03004-8 · Cited by 221 · see citing works

Predictors of sudden cardiac death in hypertrophic cardiomyopathy

Maki, S., Ikeda, H., Muro, A., Yoshida, N., Shibata, A., Koga, Y., & Imaizumi, T. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00455-x · Cited by 216 · see citing works

Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia.

Spirito, P., Rapezzi, C., Autore, C., Bruzzi, P., Bellone, P., Ortolani, P., Fragola, P. V., Chiarella, F., Zoni-Berisso, M., & Branzi, A. (1994) · Circulation · doi:10.1161/01.cir.90.6.2743 · Cited by 204 · see citing works

Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy

McLeod, C. J., Ommen, S. R., Ackerman, M. J., Weivoda, P. L., Shen, W.-K., Dearani, J. A., Schaff, H. V., Tajik, A. J., & Gersh, B. J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm117 · Cited by 203 · see citing works

Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease

Sorajja, P., Ommen, S. R., Nishimura, R. A., Gersh, B. J., Berger, P. B., & Tajik, A. J. (2003) · Circulation · doi:10.1161/01.cir.0000097110.55312.bf · Cited by 198 · see citing works

Prevalence and Severity of “Benign” Mutations in the β-Myosin Heavy Chain, Cardiac Troponin T, and α-Tropomyosin Genes in Hypertrophic Cardiomyopathy

Driest, S. L. V., Ackerman, M. J., Ommen, S. R., Shakur, R., Will, M. L., Nishimura, R. A., Tajik, A. J., & Gersh, B. J. (2002) · Circulation · doi:10.1161/01.cir.0000042675.59901.14 · Cited by 181 · see citing works

Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy

Olivotto, I., Gistri, R., Petrone, P., Pedemonte, E., Vargiu, D., & Cecchi, F. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02713-4 · Cited by 161 · see citing works

Homozygous Mutation in Cardiac Troponin T

Ho, C. Y., Lever, H. M., DeSanctis, R. W., Farver, C. F., Seidman, J. G., & Seidman, C. E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1950 · Cited by 150 · see citing works

Sudden cardiac death in hypertrophic cardiomyopathy

Marian, A. J., Mares, A., Kelly, D. P., Yu, Q., Abchee, A., Hill, R., & Roberts, R. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060920 · Cited by 139 · see citing works

Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy

Erdmann, J., Raible, J., Abadi, J. M., Hammann, J., Wollnik, B., Frantz, E., Fleck, E., Regitz‐Zagrosek, V., Hummel, M. W., & Hetzer, R. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01387-0 · Cited by 139 · see citing works

Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest

Cecchi, F., Maron, B. J., & Epstein, S. E. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90302-1 · Cited by 139 · see citing works

Clinical Features of Hypertrophic Cardiomyopathy Caused by Mutation of a “Hot Spot” in the Alpha-Tropomyosin Gene

Coviello, D. A., Maron, B. J., Spirito, P., Watkins, H. C., Vosberg, H.-P., Thierfelder, L., Schöen, F. J., Seidman, J. G., & Seidman, C. E. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00538-4 · Cited by 127 · see citing works

Prognosis in hypertrophic cardiomyopathy observed in a large clinic population

Kofflard, M. J. M., Waldstein, D. J., Vos, J., & ten Cate, F. J. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)91111-t · Cited by 127 · see citing works

Molecular Genetic Basis of Hypertrophic Cardiomyopathy:

Marian, A. J., & Roberts, R. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00871.x · Cited by 115 · see citing works

New Concepts in Hypertrophic Cardiomyopathies, Part II

Roberts, R., & Sigwart, U. (2001) · Circulation · doi:10.1161/hc4301.097430 · Cited by 113 · see citing works

Natural history of hypertrophic cardiomyopathy in the elderly

Fay, W. P., Taliercio, C. P., Ilstrup, D. M., Tajik, A. J., & Gersh, B. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80328-6 · Cited by 106 · see citing works

Genotype–phenotype correlations in familial hypertrophic cardiomyopathy A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes

Charron, P. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0575 · Cited by 105 · see citing works

Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene

Deprez, R. H. L., Muurling-Vlietman, J. J., Hruda, J., Baars, M. J. H., Wijnaendts, L. C. D., Stolte‐Dijkstra, I., Alders, M. M., & van Hagen, J. M. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.040329 · Cited by 101 · see citing works

Double heterozygosity for mutations in the β-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy

Richard, P., Isnard, R., Carrier, L., Dubourg, O., Donatien, Y., Mathieu, B., Bonne, G., Gary, F., Charron, P., Hagège, A. A., et al. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.7.542 · Cited by 92 · see citing works

Implantable Cardioverter-Defibrillator Therapy for Primary Prevention of Sudden Death After Alcohol Septal Ablation of Hypertrophic Cardiomyopathy

Cuoco, F. A., Spencer, W. H., Fernandes, V. L. C., Nielsen, C. D., Nagueh, S. F., Sturdivant, J. L., Leman, R. B., Wharton, J. M., & Gold, M. R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.061 · Cited by 89 · see citing works

Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy

Takagi, E., Yamakado, T., & Nakano, T. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00555-5 · Cited by 83 · see citing works

Incidence of Ischemic Strokes in Hypertrophic Cardiomyopathy is Markedly Increased if Complicated by Atrial Fibrillation

Higashikawa, M., Nakamura, Y., Yoshida, M., & Kinoshita, M. (1997) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.61.673 · Cited by 80 · see citing works

Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.

DEpstein, N., MCohn, G., FCyran, & LFananapazir (1992) · Circulation · Cited by 75 · see citing works

Rate-modulated cardiac pacing based on transthoracic impedance measurements of minute ventilation: Correlation with exercise gas exchange

Kay, G. N., Bubien, R. S., Epstein, A. E., & Plumb, V. J. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90429-4 · Cited by 71 · see citing works

Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy†

D’Andrea, A., Caso, P., Severino, S., Cuomo, S., Capozzi, G., Calabrò, P., Cice, G., Ascione, L., Scherillo, M., & Calabrò, R. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi688 · Cited by 64 · see citing works

Homozygotes for a R869G Mutation in the β -myosin Heavy Chain Gene have a Severe Form of Familial Hypertrophic Cardiomyopathy

Richard, P., Charron, P., Leclercq, C., Ledeuil, C., Carrier, L., Dubourg, O., Desnos, M., Bouhour, J.-B., Schwartz, K., Daubert, J., et al. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1193 · Cited by 63 · see citing works

Genotype: phenotype correlations in hypertrophic cardiomyopathy.

Watkins, H. C. (1998) · PubMed · Cited by 62 · see citing works

Hypertrophic cardiomyopathy: Is a left ventricular outflow tract gradient a major prognostic determinant?

Romeo, F., Pelliccia, F., CRISTOFANII, R., Martuscelli, E., & Reale, A. (1990) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059689 · Cited by 53 · see citing works

A new missense mutation, Arg719Gln, in the β-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy

Consevage, M. W., Salada, G. C., Baylen, B. G., Ladda, R. L., & Rogan, P. K. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.6.1025 · Cited by 52 · see citing works

Hypertrophic cardiomyopathy in the elderly: significance of atrial fibrillation.

Doi, Y., & Kitaoka, H. (2001) · PubMed · Cited by 43 · see citing works

Relation of QRS Duration to Mortality in a Community-Based Cohort With Hypertrophic Cardiomyopathy

Bongioanni, S., Bianchi, F., Migliardi, A., Gnavi, R., Pron, P. G., Casetta, M., & Conte, M. R. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.049 · Cited by 41 · see citing works

Early expression of a malignant phenotype of familial hypertrophic cardiomyopathy associated with a Gly716Arg myosin heavy chain mutation in a Korean family

Hwang, T. H., Lee, W., Kimura, A., Satoh, M., Nakamura, T., Kim, M.-K., Choi, S.-K., & Park, J.-E. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00695-x · Cited by 40 · see citing works

Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy: Figure 1

Dimitrow, P. P., & Dubiel, J. S. (2004) · Heart · doi:10.1136/hrt.2003.030353 · Cited by 30 · see citing works

The val606met mutation in the cardiac beta-myosin heavy chain gene in patients with familial hypertrophic cardiomyopathy is associated with a high risk of sudden death at young age

Havndrup, O., Bundgaard, H., Andersen, P. S., Larsen, L. A., Vuust, J., Kjeldsen, K. P., & Christiansen, M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01532-6 · Cited by 29 · see citing works

Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes

D’Andrea, A., Caso, P., Cuomo, S., Salerno, G., Scarafile, R., Mita, C., Corato, G. D., Sarubbi, B., Scherillo, M., & Calabrò, R. (2006) · British Journal of Sports Medicine · doi:10.1136/bjsm.2005.022194 · Cited by 27 · see citing works

Long-term follow-up of R403WMYH7 and R92WTNNT2 HCM families: mutations determine left ventricular dimensions but not wall thickness during disease progression.

Revera, M., van der Merwe, L., Heradien, M. J., Goosen, A., Corfield, V. A., Brink, P. A., & Moolman‐Smook, J. C. (2007) · PubMed Central · Cited by 21 · see citing works

Electrocardiographic findings in patients with hypertrophic cardiomyopathy

Pelliccia, F., Cianfrocca, C., Cristofani, R., Romeo, F., & Reale, A. (1990) · Journal of Electrocardiology · doi:10.1016/0022-0736(90)90159-y · Cited by 11 · see citing works

2018 ESC Guidelines for the diagnosis and management of syncope

Brignole, M., Moya, A., de Lange, F. J., Deharo, J.-C., Elliott, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martín, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy037 · Cited by 1,951 · see citing works

Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy

Marian, A. J., & Braunwald, E. (2017) · Circulation Research · doi:10.1161/circresaha.117.311059 · Cited by 1,403 · see citing works

Hypertrophic Cardiomyopathy

Maron, B. J., Ommen, S. R., Semsarian, C., Spirito, P., Olivotto, I., & Maron, M. S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.003 · Cited by 652 · see citing works

2018 ESC Guidelines for the diagnosis and management of syncope

Brignole, M., Moya‐Mitjans, À., de Lange, F. J., Deharo, J., Elliot, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martiın, A., et al. (2018) · Kardiologia Polska · doi:10.5603/kp.2018.0161 · Cited by 474 · see citing works

Patterns of Disease Progression in Hypertrophic Cardiomyopathy

Olivotto, I., Cecchi, F., Poggesi, C., & Yacoub, M. H. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.967026 · Cited by 352 · see citing works

Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies

Maron, B. J., Rowin, E. J., Casey, S. A., Link, M. S., Lesser, J. R., Chan, R. H. M., Garberich, R., Udelson, J. E., & Maron, M. S. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.061 · Cited by 352 · see citing works

Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy

Maron, M. S., Rowin, E. J., Wessler, B. S., Mooney, P., Fatima, A., Patel, P. P., Koethe, B. C., Romashko, M. D., Link, M. S., & Maron, B. J. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1391 · Cited by 323 · see citing works

How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality

Maron, B. J., Rowin, E. J., Casey, S. A., & Maron, M. S. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2015.0354 · Cited by 260 · see citing works

Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry

Lipshultz, S. E., Orav, E. J., Wilkinson, J. D., Towbin, J. A., Messere, J. E., Lowe, A. M., Sleeper, L. A., Cox, G. F., Hsu, D. T., Canter, C. E., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61685-2 · Cited by 207 · see citing works

Heart Rate and Heart Rate Variability of Rhesus Macaques (Macaca mulatta) Affected by Left Ventricular Hypertrophy

Ueda, Y., Slabaugh, T. L., Walker, A. L., Ontiveros, E. S., Sosa, P.-M., Reader, J. R., Roberts, J. A., & Stern, J. A. (2019) · Frontiers in Veterinary Science · doi:10.3389/fvets.2019.00001 · Cited by 193 · see citing works

Genetic testing for inherited cardiac disease

Wilde, A., & Behr, E. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.108 · Cited by 192 · see citing works

The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy

O’Mahony, C., Lambiase, P. D., Quarta, G., Cardona, M., Calcagnino, M. M., Tsovolas, K., Al-Shaikh, S., Rahman, S. M., Arnous, S., Jones, S., et al. (2011) · Heart · doi:10.1136/hrt.2010.217182 · Cited by 174 · see citing works

A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy

O’Mahony, C., Tome, M., Lambiase, P. D., Pantazis, A. A., Dickie, S., McKenna, W. J., & Elliot, P. M. (2013) · Heart · doi:10.1136/heartjnl-2012-303271 · Cited by 159 · see citing works

Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice

Baig, S., Edward, N. C., Kotecha, D., Liu, B., Nordin, S., Kozor, R., Moon, J., Geberhiwot, T., & Steeds, R. P. (2017) · EP Europace · doi:10.1093/europace/eux261 · Cited by 134 · see citing works

Sudden Cardiac Death in Hypertrophic Cardiomyopathy

O’Mahony, C., Elliot, P. M., & McKenna, W. J. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.962043 · Cited by 106 · see citing works

Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy

To, A. C. Y., Dhillon, A. S., & Desai, M. Y. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.06.022 · Cited by 97 · see citing works

Systematic Review of Pregnancy in Women with Inherited Cardiomyopathies

Krul, S. P. J., van der Smagt, J. J., van den Berg, M. P., Sollie, K. M., Pieper, P. G., & van Spaendonck‐Zwarts, K. Y. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr040 · Cited by 92 · see citing works

Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers

Lyon, A., Ariga, R., Mincholé, A., Mahmod, M., Ormondroyd, E., Laguna, P., de Freitas, N., Neubauer, S., Watkins, H. C., & Rodríguez, B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00213 · Cited by 86 · see citing works

Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy

Rowin, E. J., Maron, M. S., Chan, R. H. M., Hausvater, A., Wang, W., Rastegar, H., & Maron, B. J. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.08.048 · Cited by 76 · see citing works

A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy

Smole, T., Žunkovič, B., Pičulin, M., Kokalj, E., Robnik‐Šikonja, M., Kukar, M., Fotiadis, D. I., Pezoulas, V. C., Tachos, N. S., Barlocco, F., et al. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104648 · Cited by 75 · see citing works

Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy

Maron, B. J., & Maron, M. S. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2015.12.048 · Cited by 74 · see citing works

Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model)

Bhattacharya, M., Lu, D., Kudchadkar, S. M., Greenland, G. V., Lingamaneni, P., Corona‐Villalobos, C. P., Guan, Y., Marine, J. E., Olgin, J. E., Zimmerman, S. L., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.02.022 · Cited by 70 · see citing works

Female Sex Is Associated with Worse Prognosis in Patients with Hypertrophic Cardiomyopathy in China

Wang, Y., Wang, J., Zou, Y., Bao, J., Sun, K., Zhu, L., Tian, T., Hu, S., Zhou, X., Ahmad, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102969 · Cited by 71 · see citing works

Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy

Ismail, T. F., Prasad, S. K., & Pennell, D. J. (2011) · Heart · doi:10.1136/heartjnl-2011-300814 · Cited by 64 · see citing works

Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM)

Marian, A. J., Tan, Y., Li, L., Chang, J., Syrris, P., Hessabi, M., Rahbar, M. H., Willerson, J. T., Cheong, B., Liu, C., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312647 · Cited by 61 · see citing works

Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge

Weissler‐Snir, A., Adler, A., Williams, L. K., Gruner, C., & Rakowski, H. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw268 · Cited by 57 · see citing works

Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy

Montoro‐García, S., Hernández‐Romero, D., Jover, E., García‐Honrubia, A., Vilchez, J. A., Casas, T., Martı́nez, P., Climent, V. E., Caballero, L., Valdés, M., et al. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.08.022 · Cited by 53 · see citing works

Publication guidelines need widespread adoption

Larson, E., & Cortazal, M. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.07.008 · Cited by 50 · see citing works

Phenotypes of hypertrophic cardiomyopathy. An illustrative review of MRI findings

Soler, R., Méndez, C., Rodrı́guez, E., Villa, R. B., Ochoa, J. P., & Monserrat, L. (2018) · Insights into Imaging · doi:10.1007/s13244-018-0656-8 · Cited by 51 · see citing works

Fragmented QRS as a predictor of arrhythmic events in patients with hypertrophic obstructive cardiomyopathy

on behalf of Fragmented QRS in Hypertrophic Obstructive Cardiomyopathy (FHOCM) Study Investigators, Femenía, F., Arce, M. A., Grieken, J. V., Trucco, E., Mont, L., Abello, M., Merino, J. L., Rivero‐Ayerza, M., Görenek, B., et al. (2013) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-013-9829-z · Cited by 49 · see citing works

Genetics and Genomics of Single-Gene Cardiovascular Diseases

Marian, A. J., van Rooij, E., & Roberts, R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.968 · Cited by 48 · see citing works

Fragmented QRS as a candidate marker for high-risk assessment in hypertrophic cardiomyopathy

Kang, K., Janardhan, A. H., Jung, K. T., Lee, H. S., Lee, M., & Hwang, H. J. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.05.002 · Cited by 47 · see citing works

Anacardic acid attenuates pressure‐overload cardiac hypertrophy through inhibiting histone acetylases

Li, S., Peng, B., Luo, X., Sun, H., & Peng, C. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14181 · Cited by 45 · see citing works

Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes

Garratt, C. J., Elliot, P. M., Behr, E. R., Camm, A. J., Cowan, C., Cruickshank, S., Grace, A. A., GRIFFITH, M. J., Jolly, A., Lambiase, P. D., et al. (2010) · EP Europace · doi:10.1093/europace/euq261 · Cited by 43 · see citing works

Predictors of risk for sudden death in childhood hypertrophic cardiomyopathy: the importance of the ECG risk score

Östman‐Smith, I., Sjöberg, G., Rydberg, A., Larsson, P., & Fernlund, E. (2017) · Open Heart · doi:10.1136/openhrt-2017-000658 · Cited by 39 · see citing works

Prevention of sudden cardiac death in hypertrophic cardiomyopathy

O’Mahony, C., & Elliot, P. M. (2013) · Heart · doi:10.1136/heartjnl-2012-301996 · Cited by 36 · see citing works

Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy

Weissler‐Snir, A., Chan, R. H. M., Adler, A., Care, M. E., Chauhan, V. S., Gollob, M. H., Ziv‐Baran, T., Fourey, D., Hindieh, W., Rakowski, H., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.07.043 · Cited by 34 · see citing works

High Signal Intensity on T2-Weighted Cardiovascular Magnetic Resonance Imaging Predicts Life-Threatening Arrhythmic Events in Hypertrophic Cardiomyopathy Patients

Hen, Y., Takara, A., Iguchi, N., Utanohara, Y., Teraoka, K., Takada, K., Machida, H., Takamisawa, I., Takayama, M., & Yoshikawa, T. (2018) · Circulation Journal · doi:10.1253/circj.cj-17-1235 · Cited by 31 · see citing works

Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator

Salas, A. R., García‐Pinilla, J. M., Cabrera‐Bueno, F., Fernández-Pastor, J., Peña-Hernández, J., Medina-Palomo, C., Barrera-Cordero, A., de Teresa, E., & Alzueta, J. (2015) · EP Europace · doi:10.1093/europace/euv079 · Cited by 30 · see citing works

Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy

Thavikulwat, A. C., Tomson, T. T., Knight, B. P., Bonow, R. O., & Choudhury, L. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13005 · Cited by 30 · see citing works

Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning

Kochav, S. M., Raita, Y., Fifer, M. A., Takayama, H., Ginns, J. N., Maurer, M. S., Reilly, M. P., Hasegawa, K., & Shimada, Y. J. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.11.003 · Cited by 30 · see citing works

The role of renin–angiotensin–aldosterone system polymorphisms in phenotypic expression of MYBPC3-related hypertrophic cardiomyopathy

Kolder, I. C. R. M., Michels, M., Christiaans, I., ten Cate, F. J., Majoor‐Krakauer, D. F., Danser, A. H. J., Deprez, R. H. L., Tanck, M. W. T., Wilde, A. A. M., Bezzina, C. R., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.48 · Cited by 29 · see citing works

The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast‐enhanced magnetic resonance study

Weissler‐Snir, A., Hindieh, W., SPEARS, D. A., Adler, A., Rakowski, H., & Chan, R. H. M. (2019) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13855 · Cited by 29 · see citing works

Prevalence of HCM and long QT syndrome mutations in young sudden cardiac death-related cases

Allegue, C., Gil, R., Blanco‐Verea, A., Santori, M., Rodríguez-Calvo, M. S., Concheiro, L., Carracedo, Á., & Brión, M. (2011) · International Journal of Legal Medicine · doi:10.1007/s00414-011-0572-7 · Cited by 28 · see citing works

Heart Rate Recovery in Patients With Hypertrophic Cardiomyopathy

Patel, V., Critoph, C., Finlay, M., Mist, B., Lambiase, P. D., & Elliot, P. M. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.11.062 · Cited by 28 · see citing works

Role of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Systematic Review and Updated Meta-Analysis of Risk Markers for Sudden Death

Bittencourt, M. I., Cader, S. A., Araújo, D. V., Salles, A. L. F., Albuquerque, F. N., Spineti, P. P. D. M., de Albuquerque, D. C., & Mourilhe‐Rocha, R. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190045 · Cited by 27 · see citing works

Holter monitoring demonstrates that ventricular arrhythmias are common in cats with decompensated and compensated hypertrophic cardiomyopathy

Bartoszuk, U., Keene, B. W., Toaldo, M. B., Pereira, N., Summerfield, N., Matos, J. N., & Glaus, T. M. (2018) · The Veterinary Journal · doi:10.1016/j.tvjl.2018.11.005 · Cited by 26 · see citing works

Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy

Santoro, F., Mango, F., Mallardi, A., D’Alessandro, D., Casavecchia, G., Gravina, M., Correale, M., & Brunetti, N. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103397 · Cited by 26 · see citing works

Genotype-phenotype Correlations of Hypertrophic Cardiomyopathy When Diagnosed in Children, Adolescents, and Young Adults

Loar, R. W., Bos, J. M., Will, M. L., Ommen, S. R., & Ackerman, M. J. (2015) · Congenital Heart Disease · doi:10.1111/chd.12280 · Cited by 26 · see citing works

Demographic and Regional Trends of Hypertrophic Cardiomyopathy-Related Mortality in the United States, 1999 to 2019

Minhas, A. M. K., Wyand, R. A., Ariss, R. W., Nazir, S., Khan, M. S., Jia, X., Greene, S. J., Fudim, M., Wang, A., Warraich, H. J., et al. (2022) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.009292 · Cited by 25 · see citing works

Burden and trends of arrhythmias in hypertrophic cardiomyopathy and its impact of mortality and resource utilization

Tripathi, B., Khan, S. U., Arora, S., Kumar, V. M., Naraparaju, V., Lahewala, S., Sharma, P., Atti, V., Jain, V., Shah, M. K., et al. (2019) · Journal of Arrhythmia · doi:10.1002/joa3.12215 · Cited by 24 · see citing works

Importance of newer cardiac magnetic resonance–based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study

Rowin, E. J., Maron, M. S., Adler, A., Albano, A. J., Varnava, A. M., SPEARS, D. A., Marsy, D., Heitner, S. B., Cohen, E., Leong, K. M. W., et al. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.12.017 · Cited by 24 · see citing works

Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults

Jordà, P., & García‐Álvarez, A. (2018) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2018.25 · Cited by 22 · see citing works

Sports and Exercise in Athletes with Hypertrophic Cardiomyopathy

Alpert, C. M., Day, S. M., & Saberi, S. (2015) · Clinics in Sports Medicine · doi:10.1016/j.csm.2015.03.005 · Cited by 23 · see citing works

Post-Mortem Imaging Adjudicated Sudden Death: Causes and Controversies

Femia, G., Semsarian, C., Langlois, N. E. I., McGuire, M. A., Raleigh, J., Taylor, A. M., & Puranik, R. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.09.003 · Cited by 22 · see citing works

Comparison of 3D Phase-Sensitive Inversion-Recovery and 2D Inversion-Recovery MRI at 3.0 T for the Assessment of Late Gadolinium Enhancement in Patients with Hypertrophic Cardiomyopathy

Morita, K., Utsunomiya, D., Oda, S., Komi, M., Namimoto, T., Hirai, T., Hashida, M., Takashio, S., Yamamuro, M., & Yamashita, Y. (2013) · Academic Radiology · doi:10.1016/j.acra.2013.01.014 · Cited by 21 · see citing works

Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator

Francia, P., Ziacchi, M., Adduci, C., Ammendola, E., Pieragnoli, P., Filippo, P. D., Rapacciuolo, A., Rella, V., Migliore, F., Viani, S. M., et al. (2023) · EP Europace · doi:10.1093/europace/euad270 · Cited by 20 · see citing works

Ventricular arrhythmias: from the electrophysiology laboratory to clinical practice. Part II: potentially malignant and benign ventricular arrhythmias.

Gatzoulis, K. A., Archontakis, S., Dilaveris, P., Tsiachris, D., Αρσένος, Π., Sideris, S. K., & Stefanadis, C. (2012) · PubMed · Cited by 19 · see citing works

Risk Stratification in Hypertrophic Cardiomyopathy

Steriotis, A. K., & Sharma, S. (2015) · European Cardiology Review · doi:10.15420/ecr.2015.10.01.31 · Cited by 20 · see citing works

Distribution and Clinical Significance of High Signal Intensity of the Myocardium on T2-Weighted Images in 2 Phenotypes of Hypertrophic Cardiomyopathy

Amano, Y., Aita, K., Yamada, F., Kitamura, M., & Kumita, S. (2015) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000000296 · Cited by 20 · see citing works

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy

Maron, M. S., Rowin, E. J., Spirito, P., & Maron, B. J. (2022) · Heart · doi:10.1136/heartjnl-2020-316693 · Cited by 19 · see citing works

Role of echocardiography in the diagnosis and management of hypertrophic cardiomyopathy

Domínguez, F., González-López, E., Padrón-Barthe, L., Cavero, M. A., & García‐Pavía, P. (2017) · Heart · doi:10.1136/heartjnl-2016-310559 · Cited by 19 · see citing works

Strategies for the prevention and treatment of sudden cardiac death

Herzog, E., Javed, F., & Aziz, E. F. (2010) · Open Access Emergency Medicine · doi:10.2147/oaem.s6869 · Cited by 17 · see citing works

Holter Monitoring and Long-Term Prognosis in Hypertrophic Cardiomyopathy

Kawasaki, T., Sakai, C., Harimoto, K., Yamano, M., Miki, S., Kamitani, T., & Sugihara, H. (2012) · Cardiology · doi:10.1159/000338156 · Cited by 18 · see citing works

Myocardial tissue characterization by gadolinium-enhanced cardiac magnetic resonance imaging for risk stratification of adverse events in hypertrophic cardiomyopathy

Raiker, N. K., Vullaganti, S., Collins, J. D., Allen, B. D., & Choudhury, L. (2020) · International journal of cardiac imaging · doi:10.1007/s10554-020-01808-6 · Cited by 17 · see citing works

Risk assessment in hypertrophic cardiomyopathy: contemporary guidelines hampered by insufficient evidence

McKeown, P., & Muir, A. (2013) · Heart · doi:10.1136/heartjnl-2012-303363 · Cited by 15 · see citing works

Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death

Smith, E. D., Tome, J., McGrath, R., Kumar, S., Concannon, M., Day, S. M., Saberi, S., & Helms, A. S. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.07.110 · Cited by 15 · see citing works

Abnormal sodium channel mRNA splicing in hypertrophic cardiomyopathy

Noyes, A. M., Zhou, A., Gao, G., Gu, L., Day, S. M., Wasserstrom, J. A., & Dudley, S. C. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.08.071 · Cited by 15 · see citing works

Alcohol septal ablation in patients with severe septal hypertrophy

Veselka, J., Jensen, M. K., Liebregts, M., Cooper, R. M., Januška, J., Kashtanov, M. G., Dąbrowski, M., Hansen, P. R., Seggewiß, H., Hansvenclová, E., et al. (2019) · Heart · doi:10.1136/heartjnl-2019-315422 · Cited by 15 · see citing works

LEOPARD Syndrome Caused by Tyr279Cys Mutation in the PTPN11 Gene

Martínez‐Quintana, E., & Rodríguez-González, F. (2011) · Molecular Syndromology · doi:10.1159/000335995 · Cited by 15 · see citing works

Validation of Guideline Recommendation on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy

Amano, M., Kitaoka, H., Yoshikawa, Y., Sakata, Y., Dohi, K., Tokita, Y., Kato, T., Matsushima, S., Kitai, T., Okada, A., et al. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2024.12.006 · Cited by 14 · see citing works

Risk stratification in hypertrophic cardiomyopathy

Marrakchi, S., Kammoun, I., Bennour, E., Laroussi, L., & Kachboura, S. (2018) · Herz · doi:10.1007/s00059-018-4700-8 · Cited by 14 · see citing works

Family History of Sudden Death Should Be a Primary Indication for Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy

Maron, M. S. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.05.004 · Cited by 13 · see citing works

Surface fragmented QRS in a patient with hypertrophie cardiomyopathy and malignant arrhythmias: ls there an association?

Femenía, F., Arce, M., Arrieta, M., & Baranchuk, A. M. (2012) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.91602 · Cited by 13 · see citing works

Cardiac MRI evaluation of hypertrophic cardiomyopathy: Left ventricular outflow tract/aortic valve diameter ratio predicts severity of LVOT obstruction

Vogel‐Claussen, J., Tomas, M. S., Newatia, A., Boyce, D. M., Pinheiro, A. C., Abraham, R. M., Abraham, T. P., & Bluemke, D. A. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23677 · Cited by 13 · see citing works

Supraventricular tachycardia in 23 cats; comparison with 21 cats with atrial fibrillation (2004–2014)

Greet, V., Sargent, J., Brannick, M., & Fuentes, V. L. (2020) · Journal of Veterinary Cardiology · doi:10.1016/j.jvc.2020.04.007 · Cited by 12 · see citing works

Extended ambulatory ECG monitoring enhances identification of higher-risk ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy

Rowin, E. J., Das, G., Madias, C. A., Hsu, M., Crosson, L. A., Turakhia, M. P., Maron, B. J., & Maron, M. S. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.09.040 · Cited by 11 · see citing works

Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy

Du, D., Li, C. O. Y., Ong, K., Parsa, A., Weissler‐Snir, A., Geske, J. B., & Laksman, Z. (2022) · CJC Open · doi:10.1016/j.cjco.2022.01.001 · Cited by 11 · see citing works

HYPERTROPHIC CARDIOMYOPATHY: GENETIC ALTERATIONS, PATHOGENESIS AND PATHOPHYSIOLOGY

Vatutin, N. T., Тарадин, Г. Г., & Maron, M. S. (2014) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2014-5-35-42 · Cited by 11 · see citing works

Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: A study from the French register of hypertrophic cardiomyopathy (REMY)

Mirabel, M., Damy, T., Donal, E., Huttin, O., Labombarda, F., Eicher, J., Cervino, C. O., Laurito, M., Offredo, L., Tafflet, M., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.09.083 · Cited by 11 · see citing works

The relationship between β1‐adrenergic and M2‐muscarinic receptor autoantibodies and hypertrophic cardiomyopathy

Duan, X., Liu, R., Luo, X., Gao, X., Hu, F., Guo, C., Wang, J., Hu, X., Chun, Y., Yuan, J., et al. (2019) · Experimental Physiology · doi:10.1113/ep088263 · Cited by 11 · see citing works

Hypertrophic Cardiomyopathy: Challenging the Status Quo?

Younger, J. F., Lo, A., McCormack, L., McGaughran, J. M., Prasad, S. B., & Atherton, J. J. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.12.005 · Cited by 10 · see citing works

Rapid Device‐Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy

VISWANATHAN, K., Suszko, A. M., Das, M., Jackson, N. M., Gollob, M. H., CAMERON, D. A., SPEARS, D. A., Woo, A., Rakowski, H., Khurana, M., et al. (2016) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12861 · Cited by 10 · see citing works

Incremental Value of an Insertable Cardiac Monitor in Patients with Hypertrophic Cardiomyopathy with Low or Intermediate Risk for Sudden Cardiac Death

Sakhi, R., Huurman, R., Theuns, D. A. M. J., Schinkel, A. F. L., Assaf, A., Szili‐Törok, T., Roos‐Hesselink, J. W., Michels, M., & Yap, S. (2021) · Cardiology · doi:10.1159/000512656 · Cited by 10 · see citing works

Terapia con desfibrilador automático implantable en la miocardiopatía hipertrófica: utilidad en prevención primaria y secundaria

Sarrias, A., Galve, E., Sabaté, X., Moya‐Mitjans, À., Anguera, I., Núñez, E., Villuendas, R., Alcalde, Ó., & David Garcia-dorado, A. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.05.024 · Cited by 9 · see citing works

Mid-term outcomes of biventricular obstruction and left ventricular outflow tract obstruction after surgery correction in child and adolescent patients with hypertrophic cardiomyopathy

Zhai, S., Xu, H., Fan, C., Yang, Y., Hang, F., Guo, X., Wang, H., Duan, F., & Yan, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192218 · Cited by 9 · see citing works

Epidemiology of Heart Failure

Dahlström, U. (2019) · Cardiovascular medicine · doi:10.1007/978-3-319-98184-0_1 · Cited by 8 · see citing works

Additive prognostic significance of ejection fraction for ESC risk model in hypertrophic cardiomyopathy patients

Hen, Y., Iguchi, N., Kanisawa, M., Takada, K., Machida, H., Takara, A., Teraoka, K., Takamisawa, I., Takayama, M., & Yoshikawa, T. (2019) · Heart and Vessels · doi:10.1007/s00380-019-01496-w · Cited by 8 · see citing works

Almanac 2014: cardiomyopathies

Guttmann, O. P., MOHIDDIN, S. A., & Elliot, P. M. (2014) · Heart · doi:10.1136/heartjnl-2013-305420 · Cited by 8 · see citing works

Risk stratification in hypertrophic cardiomyopathy

Pacileo, G., Salerno, G., Gravino, R., Calabrò, R., & Elliot, P. M. (2012) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328357739e · Cited by 7 · see citing works

The Role of Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy

Marchesini, M., Uguccioni, L., Parisi, R., Mattioli, G., Terzi, F., Olivieri, R., Capucci, A., & Fattori, R. (2016) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0811 · Cited by 7 · see citing works

Risk Factors for Sudden Death in Athletes, Is There a Role for Screening?

HAJDUCZOK, A. G., Ruge, M., & Emery, M. S. (2022) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-022-00697-9 · Cited by 7 · see citing works

Hypertrophic cardiomyopathy

Östman‐Smith, I., Rossano, J. W., & Shaddy, R. E. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32835dd020 · Cited by 7 · see citing works

Risk factors for sudden cardiac death to determine high risk patients in specific patient populations that may benefit from a wearable defibrillator

Khan, H., & Leslie, S. J. (2019) · World Journal of Cardiology · doi:10.4330/wjc.v11.i3.103 · Cited by 7 · see citing works

Discordância entre Diretrizes Internacionais sobre Critérios de Prevenção Primária de Morte Súbita na Cardiomiopatia Hipertrófica

Mattos, B. P. E., Scolari, F. L., & Garbin, H. I. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20190161 · Cited by 7 · see citing works

PET-CT Imaging in Hypertrophic Cardiomyopathy: A Narrative Review on Risk Stratification and Prognosis

Marques‐Alves, P., Gonçalves, L. M. M., & Ferreira, M. J. (2025) · Diagnostics · doi:10.3390/diagnostics15020133 · Cited by 6 · see citing works

Evaluation of sudden cardiac death in hypertrophic cardiomyopathy

Yoon, S. G., & Hong, G. (2025) · Journal of Cardiovascular Imaging · doi:10.1186/s44348-025-00054-5 · Cited by 6 · see citing works

Demographics and Trends of Hypertrophic Cardiomyopathy-Related Mortality in the United States, 1999-2020

Renjihtlal, S. L. M., Eid, M., Vyas, C., Mohamed, S., Shanmukhappa, S., Renjith, K., Mostafa, M. R., Baibhav, B., & Pillai, N. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101681 · Cited by 6 · see citing works

Prognostic value of cardiovascular magnetic resonance imaging for life-threatening arrhythmia detected by implantable cardioverter-defibrillator in Japanese patients with hypertrophic cardiomyopathy

Hen, Y., Tsugu-Yagawa, M., Iguchi, N., Utanohara, Y., Takada, K., Machida, H., Takara, A., Teraoka, K., Inoue, K., Takamisawa, I., et al. (2017) · Heart and Vessels · doi:10.1007/s00380-017-1030-3 · Cited by 6 · see citing works

Prognostic impact of mitral L-wave in patients with hypertrophic cardiomyopathy without risk factors for sudden cardiac death

Sugiura, Y., Morimoto, R., Aoki, S., Yamaguchi, S., Haga, T., Kuwayama, T., Yokoi, T., Hiraiwa, H., Kondo, T., Watanabe, N., et al. (2019) · Heart and Vessels · doi:10.1007/s00380-019-01440-y · Cited by 5 · see citing works

Risk factors of sudden cardiac death in hypertrophic cardiomyopathy

Hong, Y., SU, W. W., & Li, X. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000939 · Cited by 46 · see citing works

Reverse Septal Curvature: A Novel Comprehensive Risk Marker of Nonsustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy

Ilkhanoff, L., & deFilippi, C. R. (2024) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2024.01.002 · Cited by 1 · see citing works

Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy

Miller, M. A., Gomes, J. A., & Fuster, V. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1057 · Cited by 24 · see citing works

Additional factors associated with sudden cardiac death in HCM patients

Butko, O. O., & Tseluyko, V. (2024) · EP Europace · doi:10.1093/europace/euae102.538

Risk factors for sudden cardiac death in hypertrophic cardiomyopathy

Efthimiadis, G. K., Parcharidou, D. G., Pagourelias, E. D., Ziakas, A., Mantzari, E., Pliakos, C. I., Karvounis, H. I., Stylıadis, I., & Parcharidis, G. E. (2009) · Aristotle University Medical journal/Aristotle University Medical Journal